Title: Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a
disproportionality analysis from the FAERS database
Version: 1 Date: 20 Jun 2025
Reviewer's report:
Thank you for the thorough revisions. I have no additional comments, aside from a few
grammatical errors that still need to be corrected.
Title: Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a
disproportionality analysis from the FAERS database
Version: 1 Date: 20 Jun 2025
Reviewer's report:
Thank you for the thorough revisions. I have no additional comments, aside from a few
grammatical errors that still need to be corrected.
Please review this paper.
user
Title: Safety of infliximab and adalimumab in pediatric inflammatory bowel diseases: a
disproportionality analysis from the FAERS database
Version: 1 Date: 20 Jun 2025
Reviewer's report:
Thank you for the thorough revisions. I have no additional comments, aside from a few
grammatical errors that still need to be corrected.
assistant